NUcleic acid Linked Immuno-Sandwich Assay Reagents
ID: 75N95025Q00065Type: Combined Synopsis/Solicitation
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNATIONAL INSTITUTES OF HEALTH NIDABethesda, MD, 20892, USA

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413)

PSC

MEDICAL- LABORATORY TESTING (Q301)
Timeline
    Description

    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking proposals for the procurement of NUcleic acid Linked Immuno-Sandwich Assay Reagents, aimed at enhancing biomarker discovery for neurodegenerative disease research at the Center for Alzheimer’s Disease and Related Dementias (CARD). The acquisition includes the Alamar NULISAseq Inflammation Panel, with a requirement for 30 units that must demonstrate high sensitivity in analyzing over 250 proteins from minimal sample volumes, ensuring compatibility with the ARGO proteomics platform. This procurement is critical for advancing research capabilities in the detection of biomarkers related to Alzheimer’s Disease and Related Dementias (ADRD). Interested vendors must submit their quotations by January 22, 2025, at 12:00 PM Eastern Time, to Andrea Clay at amcgee@nida.nih.gov, and must comply with all specified federal regulations and provisions outlined in the solicitation.

    Point(s) of Contact
    Files
    Title
    Posted
    The document outlines the "Representation Regarding Certain Telecommunications and Video Surveillance Services or Equipment," which is a critical part of compliance in federal contracts. It establishes a framework for Offerors to declare whether they use or provide covered telecommunications equipment or services, as per the John S. McCain National Defense Authorization Act for Fiscal Year 2019. The document details two main prohibitions under Section 889, which prevent agencies from procuring equipment that either uses or is composed of covered telecommunications components. Offerors must conduct a reasonable inquiry and complete specified representations, providing additional disclosure if they indicate the use of such equipment or services. The representation and disclosures focus on identifying, describing, and examining the proposed use of covered telecommunications services, emphasizing the importance of adhering to federal guidelines. The document's objective is to mitigate risks associated with critical technologies in government contracts, ensuring that federal agencies avoid contracts with entities using potentially compromised telecommunications systems.
    The document outlines the "Covered Telecommunications Equipment or Services-Representation" requirement from the federal government, specifically under clause 52.204-26. Its primary purpose is to ensure that offerors disclose whether they supply or utilize any "covered telecommunications equipment or services" as they engage in contracts or subcontracts with the government. The term "covered telecommunications equipment or services" is defined in a related clause (52.204-25), and offerors are required to conduct a reasonable inquiry into their use of such equipment or services. Additionally, they must review the System for Award Management (SAM) for excluded entities regarding these services. The document necessitates a signed representation by an authorized individual from the organization submitting the offer, confirming compliance with these requirements. This provision is crucial in the context of federal RFPs and grants, ensuring that government contracts do not involve potentially harmful telecommunications products or services while promoting accountability in procurement processes.
    The document outlines the Federal Acquisition Regulation (FAR) requirements for contracts involving commercial products and services, specifically focusing on contractor obligations to comply with various statutory and executive order provisions. Key clauses incorporate elements related to business ethics, whistleblower protections, and subcontracting practices, emphasizing requirements for reporting executive compensation and ensuring small business participation. The stipulations include various FAR clauses, which address limitations on subcontracting, labor standards, and procurement practices related to domestic and foreign products. Additionally, it mandates compliance with regulations concerning environmental considerations, workers' rights, and anti-trafficking measures. The structure categorizes requirements into sections addressing compliance with commercial service contracts, audit access rights, as well as stipulations for subcontractor obligations, notably regarding service contract labor standards. This guidance serves to ensure that contractors align with federal regulations, fostering transparency, accountability, and equitable business practices in government procurement processes. Overall, the document plays a vital role in ensuring that contracts adhere to established legal frameworks, promoting fair trade practices, ethical governance, and compliance with governmental procurement laws.
    The updated document outlines the invoicing and payment provisions applicable to all Purchase Orders, Task or Delivery Orders, and Blanket Purchase Agreements (BPA) utilized by the NIH. It establishes the requirements for a proper invoice, which must include essential details such as vendor information, unique identifiers, and a three-way match for payment processing. Invoices must be submitted electronically via the Department of Treasury’s Invoice Processing Platform (IPP) or through authorized alternate procedures. The payment timelines are defined, stating that payments are due 30 days after receipt of a proper invoice or government acceptance of services. Special provisions for interest penalties are included if payments are late, alongside mandates for contractors to make accelerated payments to small business subcontractors. The document emphasizes compliance with federal regulations governing invoice submission and payment requests, ensuring streamlined operations in federal procurement. Overall, it serves to improve vendor relations and payment efficiency within federal contracting processes.
    This government document outlines a request for procurement regarding the acquisition of NUcleic acid Linked Immuno-Sandwich Assay reagents, aimed at facilitating biomarker discovery for neurodegenerative disease research at the Center for Alzheimer’s Disease and Related Dementias (CARD). The purpose of this acquisition is to enable advanced analysis of cellular proteomics to detect biomarkers related to Alzheimer’s Disease and Related Dementias (ADRD). Specific product requirements include the Alamar NULISAseq Inflammation Panel in a quantity of 30, which must provide high sensitivity in analyzing over 250 proteins from minimal sample volumes, attomolar sensitivity for low abundance proteins, and compatibility with the ARGO proteomics platform. Deliverables must adhere to government shipping and packaging specifications, and all materials must be in immediately usable condition upon delivery, which is expected within three months of purchase order receipt. This procurement is indicative of the government’s commitment to advancing research capabilities in critical health areas through targeted acquisitions.
    Lifecycle
    Title
    Type
    Combined Synopsis/Solicitation
    Similar Opportunities
    Assay Kits for Lumipulse instrument
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking proposals for the procurement of assay kits for the Lumipulse instrument, aimed at quantifying specific biomarkers related to Alzheimer's Disease. The acquisition includes a total of 4,410 assays for measuring abeta42, abeta40, and pTau 217, which will support ongoing research into cognitive decline and neurodegeneration using samples from the Baltimore Longitudinal Study of Aging. Interested vendors must submit their quotations by 5:00 p.m. Eastern Time on January 15, 2025, and can direct inquiries to Iris Merscher at iris.merscher@nih.gov or by phone at 301-827-2547. This procurement is conducted under simplified acquisition procedures and is open to all qualified offerors without set-aside restrictions.
    SOURCES SOUGHT: Mass Spectrometry Reagents
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute on Aging (NIA), is seeking qualified small business sources for the procurement of specialized Mass Spectrometry Reagents aimed at advancing research on Alzheimer’s Disease and related dementias. The objective is to establish a national resource of isogenic induced pluripotent stem cell (iPSC) lines to study genetic mutations associated with these diseases, thereby accelerating mechanistic discovery. This procurement is critical for enhancing the understanding of Alzheimer’s disease mechanisms and includes specific requirements for HPLC columns and related supplies, with the first delivery expected by July 7, 2025, and additional options extending to July 2027. Interested parties should submit their capability statements to Rashiid Cummins at Rashiid.Cummins@nih.gov by January 21, 2025, at 3:00 PM Eastern Time.
    Acquisition of SomaScan 7K and 11K Assay Kits
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking to procure fifty-nine (59) SomaScan 7K and/or 11K Assay Kits on a sole source basis from SomaLogic Operating Co., Inc. This acquisition is intended to support the Center for Human Immunology, Inflammation, and Autoimmunity (CHI) in their systems biology research, which involves measuring a wide range of proteins in various human biological samples to enhance understanding of the immune system and related diseases. The procurement aligns with federal initiatives to advance health science research capabilities, with an estimated delivery date for the products set for December 20, 2024, and a performance period from February 21, 2025, to February 20, 2026. Interested vendors may contact Kathy Song at kathy.song@nih.gov for further information and must submit their capabilities statements within 15 days of this notice.
    Brand name or equal, Reagent needed for amplification of DNA for next generation sequencing in high-throughput assay for chromatin for The National Center for Advancing Translational Sciences (NCATS)
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH) is seeking suppliers for a brand name or equal reagent necessary for the amplification of DNA for next-generation sequencing in high-throughput assays for chromatin, specifically for the National Center for Advancing Translational Sciences (NCATS). The procurement aims to acquire the NEBNext Ultra II Q5 Master Mix in a bulk order of 500 mL, which is critical for optimizing protocols and facilitating high-throughput screening. This reagent is essential for advancing medical research and enhancing the development of diagnostics and therapeutics across various human diseases. Interested vendors must submit their capability statements and relevant documentation by January 22, 2025, at 9 am Eastern Time to Giuliana Faller at giuliana.faller@nih.gov.
    Chemistry Analyzer Piccolo Xpress, CLIA Waived (AMBIS 2247161)
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking quotes for the procurement of two Piccolo Xpress Chemistry Analyzers, essential for ongoing clinical trials in Kenya. The analyzers must be brand-name Piccolo Xpress models to ensure compatibility and continuity with existing laboratory equipment, as they are critical for accurate and reliable diagnostic testing in the Vaccine Research Center's post-discharge study. This procurement reflects the NIH's commitment to enhancing clinical diagnostics capabilities through efficient and portable testing solutions. Interested vendors must submit their quotes by January 13, 2025, at 4:00 PM EST, and can direct inquiries to Rita Davis at rita.davis@nih.gov or Tonia Alexander at talexander@niaid.nih.gov.
    SOURCES SOUGHT: Automated Cell Dissociation Apparatus
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking qualified small businesses to provide an automated cell dissociation apparatus for the National Institute on Aging's Laboratory of Neurogenetics. The primary objective of this procurement is to acquire equipment capable of isolating single nuclei from human and mouse brain tissues, which is crucial for advancing research on neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS), Parkinson's disease, and Alzheimer's disease. The preferred model for this apparatus is the S2 Genomics Singulator 100 Cell Dissociation Platform, which must meet specific requirements including bench-top compatibility, single-use cartridges, and customizable software for protocol adjustments. Interested companies must submit their capability statements by January 17, 2025, to Rashiid Cummins at rashiid.cummins@nih.gov, ensuring they include all necessary documentation and adhere to the specified format.
    SERVICE AGREEMENT FOR THERMO ELECTRON LABORATORY EQUIPMENT (AMBIS 2247584)
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH) through the National Institute of Allergy and Infectious Diseases (NIAID), is soliciting quotes for maintenance agreements on Thermo Electron laboratory equipment, critical for research involving complex proteomic data. The procurement, identified by solicitation number RFQ-NIAID-25-2247584, requires comprehensive service plans for various mass spectrometry instruments, ensuring prompt maintenance response times, priority technical support, and regular preventive maintenance visits. This equipment is essential for analyzing high-value samples in ongoing research projects, and the contract period spans from March 19, 2025, to March 18, 2026. Interested vendors must submit their quotes electronically by December 30, 2024, and can contact Kimberly Rubio at kimberly.rubio@nih.gov for further information.
    GOLD SERVICE PLAN ANNUAL RENEWAL FOR MICROBETA LUMIJET INSTRUMENTS
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking quotes for the annual renewal of the Gold Service Plan for two Microbeta2 Lumijet instruments, which are critical for research conducted by the Virology Core Laboratory. This procurement involves a 12-month service agreement that includes preventive maintenance, unlimited repair services, and technical support for both instruments, ensuring reliable data collection essential for vaccine development against infectious diseases. Interested vendors must submit their quotes via the NIH's electronic Simplified Acquisition Submission System (eSASS) by January 13, 2025, at 1:00 PM EST, and can contact Angela Puddy or Tonia Alexander for further information.
    Notice of Intent BD Rhapsody Single-Cell Analysis Reagent Kits
    Active
    Health And Human Services, Department Of
    Notice of Intent BD Rhapsody Single-Cell Analysis Reagent Kits The Department of Health and Human Services, Department of, National Institutes of Health, is planning to procure BD Rhapsody Single-Cell Analysis Reagent Kits. These kits are used for the manufacture of human cells and tissue-based products utilized in phase I/II clinical protocols for transplantation, adoptive immunotherapy, and gene therapy conducted in the Clinical Center at the NIH. The procurement includes a standing order for multi-type sequencing kits and reagents with a short shelf life. The contractor will be responsible for shipping the sufficient reagents and kits following the scheduled delivery dates. The shelf life of the sequencing reagents should be at least 3 months, and the shelf life of library generation kits should be at least 6 months. The contractor is also required to provide technical support for all kits and reagents at no additional cost. The period of performance for this procurement is from 5/1/2024 to 8/30/2024. The delivery schedule is overnight delivery Monday through Thursday to the Center for Cellular Engineering (CCE) at NIH/CC in Bethesda, MD. The vendor will be responsible for ensuring the safe transport of cryopreserved patient cells and maintaining the temperature and other parameters during the shipment of reagents and kits. The contractor will be paid per product delivered and is required to provide hard copies of proofs of each product delivered. Interested parties can submit their capabilities to the Office of Purchasing and Contracts by May 1st, 9:00 AM EST. Please note that this is not a request for proposal.
    Maintenance service for Mass Spectrometers and components
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking qualified small businesses to provide maintenance services for Mass Spectrometers and associated components utilized by the National Institute on Aging (NIA). The procurement aims to ensure the proper functioning of critical instruments, including the Q Exactive HF and Orbitrap Eclipse Tribid, which are essential for ongoing research in discovery proteomics and aging studies. Interested vendors must submit a capability statement detailing their qualifications, including employee numbers and relevant experience, by January 17, 2025, at 5:00 PM EST, to Iris Merscher at iris.merscher@nih.gov. This notice is a Sources Sought announcement and does not constitute a solicitation for proposals.